CPIC and PGx discussed in recent GEN article

A recent article in Genetic Engineering & Biotechnology News (GEN) discusses the future of pharmacogenetics in the context of clinical practice. The article notes that personalized medicine will likely be enacted through the work of intermediary groups, such as the Clinical Pharmacogenetics Implementation Consortium (CPIC), who can help clinicians keep up with the latest genetic information. The article interviews Dr. Kelly Caudle, CPIC coordinator, and Dr. Robert Freimuth, co-chair of the CPIC Informatics Working Group, on how the consortium is working to enable the translation of genetic information into actionable clinical results. Ongoing work of Dr. Stuart Scott at the Icahn School of Medicine at Mount Sinai and several European institutes is also discussed.